EMIS Group Live Discussion

Live Discuss Polls Ratings Documents
Page

Alan Tittymarsh 04 Sep 2015

Re: NEW ARTICLE: Chart breakout at healthy E... Good, solid reliable IT company which I'm glad I invested in back in Jan 2014. One of the very few AIM IT companies seemingly not run by sharks or wide boys. I hope it stays that way.

II Editor 04 Sep 2015

NEW ARTICLE: Chart breakout at healthy EMIS "LSE:EMIS:EMIS, which had already flagged in-line trading during its first half, has now confirmed it is fit and healthy, with earnings growth showcasing progress across all its businesses and bankrolling a tasty boost to the dividend. And the ..."[link]

nk1999 19 Jun 2015

HL View "We highlighted Emis, the UK's leading provider of connected healthcare software, back in February as a company that benefits from a high proportion of recurring revenues. Since then, investors have warmed to the story and the shares have outperformed the FTSE All Share index by around 10%. Emis now commands a market capitalisation of £600m, up from £200m when it listed on AIM five years ago; although please remember past performance is not a guide to the future.Full year results in March were encouraging. Adjusted operating profit grew by 25%, with double digit organic growth further boosted by recent acquisitions. A robust order book and contract pipeline gives the group “considerable confidence in further sustained growth”.One of the core aims of the NHS is to 'digitalise' patient records and allow data to be shared across the entire healthcare system. Emis is a key enabler of this. The group’s software allows clinicians to view patients’ clinical history at the touch of a button and share crucial information. Its software also allows patients to book appointments and order repeat prescriptions online, as well as viewing medical records.The shares trade on a forward P/E of around 20x, a small premium to their long run average of circa 19x, with earnings per share forecast to grow by 14% this year, according to consensus analyst estimates. The shares also offer a prospective yield of 2.2% (variable and not guaranteed)."nk

IOMINVESTCOM 08 Apr 2015

SCSW effect For me the stand out share of this issue is EMIS so much so I have looked at the charts to get upto speed with them. A lot is priced into the share but.... Attached long term chart showing the trend direction. Also, looking at the run from early 2014 to now I think profit taking is setting in as we get close to previous highs around 9.15. Some looking to bank profits as the SP gets towards 9.80 broker targets.[link] I have looked a likely retracement areas that the SP could find support after the SCSW effect short term and come up with:- My starting point / stand out figure for me 6.70 (early 2014 break higher) – 9.15 (recent highs) = Difference 2.45 38.2% – 0.94p = 8.2150% – 1.225 = 7.9261.8% – 1.51 = 7.64 So the above are my areas I will for with the current pullback already reached 23.6% of 8.52 (See fibs image on 2nd image with it’s own fib levels)[link] next support 8.05 looks likely when 8.52 breaks. (Note on the 1yr chart the 200 ema kicks in at 7.93 at the same 50% retracement area.)[link] div next week 9th April. All of the above excludes the SCSW effect on the share price next week which could change direction short term.

Page